Revenue · 2017–2025
Twist Bioscience revenue
$377M+20.3% · FY2025
Twist Bioscience (TWST) reported $377M in revenue for fiscal 2025, +20.3% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-09-30 | $377M | +20.3% | Open → |
| FY20242024-09-30 | $313M | +27.7% | Open → |
| FY20232023-09-30 | $245M | +20.4% | Open → |
| FY20222022-09-30 | $204M | +53.8% | Open → |
| FY20212021-09-30 | $132M | +46.9% | Open → |
| FY20202020-09-30 | $90.1M | +65.7% | Open → |
| FY20192019-09-30 | $54.4M | +113.9% | Open → |
| FY20182018-09-30 | $25.4M | +136.2% | Open → |
| FY20172017-09-30 | $10.8M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +55.9%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Twist Bioscience revenue |url=https://companiesranked.com/en/company/twist-bioscience/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Twist Bioscience revenue. CompaniesRanked. https://companiesranked.com/en/company/twist-bioscience/revenueBibTeX
@misc{companiesranked-en-company-twist-bioscience-revenue-2026,
author = {{CompaniesRanked}},
title = {{Twist Bioscience revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/twist-bioscience/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.